Afatinib is effective in the treatment of lung adenocarcinoma with uncommon EGFR p.L747P and p.L747S mutations
| Image |  |
|---|---|
| Description | scientific article published on 17 May 2019 |
| Author/s |
author: Jen-Chung Ko James Chih-Hsin Yang |
| Publication date | May 17, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |